RxDoctor Payments Data

Gregory Heiser, PA

Nurse Practitioner · Greenville, OHNPI 1053763672

Payments from drug & device makers

$211in general payments, 2019–2025

Across 15 payments — averaging $14.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$54
  • Teva Pharmaceuticals USA, Inc.$50
  • Sanofi-aventis U.S. LLC$17
  • Novo Nordisk$14
  • Biohaven Pharmaceuticals, Inc.$14
  • Daiichi Sankyo Inc.$13
  • plus $48 from 4 others

What the payments were for

  • Food & beverage$211100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$211 in reported general payments places this provider in the 65th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$3,741
Medicare patients
140
Services billed
272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin73$61,705
TrulicityDulaglutide34$44,508
OzempicSemaglutide33$39,144
Tresiba Flextouch U-200Insulin Degludec16$24,649
EliquisApixaban25$23,428
Incruse ElliptaUmeclidinium Bromide20$15,162
JanuviaSitagliptin Phosphate12$12,748
Spiriva HandihalerTiotropium Bromide13$11,156
Spiriva RespimatTiotropium Bromide18$10,872
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$10,149
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$8,888
Humalog Kwikpen U-100Insulin Lispro13$3,447
Atorvastatin Calcium386$2,878
Albuterol Sulfate HfaAlbuterol Sulfate100$2,257
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$1,801

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$11$72,57791 claims
Novo NordiskOzempic$14$39,14433 claims
GSKIncruse Ellipta, Anoro Ellipta, Trelegy Ellipta$13$34,19952 claims
AbbVieSynthroid$12$75711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,700 nurse practitioner providers in Ohio.

Other nurse practitioner in Greenville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →